Skip to main content
Read about

Symbicort vs Albuterol: Which inhaler should you use and when does each one make sense?

Symbicort vs albuterol
On this page
Tooltip Icon.
Written by Andrew Le, MD.
Medically reviewed by
Last updated December 15, 2025

Try our free symptom checker

Get a thorough self-assessment before your visit to the doctor.

Breathing problems can feel scary, especially when they come on fast or keep returning day after day. Medicines like Symbicort and albuterol exist to help, but they do very different jobs inside your lungs. One works in the background every day. The other steps in during sudden trouble.

What is the main purpose of Symbicort and Albuterol?

Symbicort is designed for daily control. It helps keep the airways calm over time. It reduces swelling inside the lungs and helps the airway muscles stay relaxed so breathing remains steady throughout the day and night.

Albuterol has a very different role. It is a rescue medicine. It works fast when breathing suddenly becomes difficult. It opens the airways quickly during asthma attacks, COPD flare-ups, or exercise-related breathing problems.

Because of this difference, these two inhalers are not interchangeable. One protects. The other rescues.

How does Symbicort work step by step?

Symbicort contains two medicines that work together.

  1. The first medicine is budesonide. Budesonide is a corticosteroid. It lowers inflammation inside the lungs. When swelling goes down, air can move through the airways more easily. Irritation becomes less intense. Coughing and tightness become easier to control.
  2. The second medicine is formoterol. Formoterol is a long-acting bronchodilator. It relaxes the smooth muscles that wrap around the airways. When these muscles relax, the airways stay wider for longer periods. This makes breathing feel less strained.

These medicines help control asthma and COPD symptoms over time. This combination matters. Formoterol alone has been linked to higher risk in asthma patients. When combined with budesonide, that risk does not appear. This is why Symbicort is considered safe when used as prescribed.

National Institutes of Health guidelines support the use of Symbicort as SMART therapy for people with moderate to severe persistent asthma. SMART stands for Single Maintenance And Reliever Therapy. Under this plan, the same inhaler can be used every day and also during symptoms. There is a limit. The maximum is usually 8 to 12 puffs per day, depending on age.

This approach helps reduce flare-ups before they become severe. It also gives more stable asthma control over time.

How does albuterol work so quickly?

Albuterol works in a more direct and rapid way. It is a short-acting beta-agonist, also called a SABA. It targets β2 receptors in the airway muscles. Once it binds to these receptors, the muscles relax. As a result, the airways open fast.

This quick action is critical during sudden breathing trouble. During an asthma attack or bronchospasm, every second matters. Albuterol helps restore airflow within minutes.

Albuterol does have a mild effect on β1 receptors in the heart. This explains why some people notice a faster heartbeat or shakiness. Still, most of its action stays focused on the lungs.

Studies show that inhaled albuterol mainly works locally. Even when blood levels reach about 3 ng/mL after high doses, the drug’s main effect stays in the airways. This makes it useful for emergencies without heavily affecting the whole body.

Albuterol is not designed for daily control. It treats symptoms when they happen. It does not reduce lung inflammation over time.

When are Symbicort and Albuterol prescribed?

Struggling to tell the difference between a daily controller inhaler and a rescue inhaler?

Who should use Symbicort and for what reasons?

Symbicort is prescribed for asthma patients aged 6 and older when symptoms remain uncontrolled with inhaled steroids alone. Doctors may also prescribe it when a patient needs both an inhaled corticosteroid and a long-acting bronchodilator from the start.

Symbicort 160/4.5 is approved for adults with chronic obstructive pulmonary disease. This includes chronic bronchitis and emphysema. In COPD, Symbicort helps maintain airflow and lowers the risk of flare-ups.

There is an important warning that must be clear. Symbicort is not meant for sudden breathing emergencies unless specifically used under SMART therapy guidance. According to the manufacturer, it should not be used for acute bronchospasm unless a doctor has instructed otherwise.

Many patients misunderstand this point. Daily control medicine does not replace a rescue inhaler unless a doctor clearly says so.

Who should use albuterol and when is it needed?

Albuterol is prescribed to treat wheezing, chest tightness, coughing, and shortness of breath caused by asthma or COPD. It belongs to a group of medicines called bronchodilators.

Albuterol is the inhaler you reach for when symptoms start suddenly. It provides fast relief during asthma attacks and COPD flare-ups.

It comes in several forms. These include inhalers, tablets, syrups, and extended-release tablets. Inhalers are the most common choice for lung diseases.

Some people use albuterol before exercise to prevent exercise-induced breathing problems. Others use it only during emergencies.

Albuterol helps control symptoms. It does not cure asthma or COPD. Frequent use often signals poor disease control and should prompt a conversation with a doctor.

How are Symbicort and Albuterol used correctly?

Using the right inhaler the wrong way can limit relief—are you taking yours correctly?

What is the correct way to take Symbicort?

Symbicort is usually taken twice daily. The standard dose is two puffs in the morning and two puffs in the evening. The inhaler includes a dose counter, which helps track usage.

Its half-life is about 7.9 hours. This supports its twice-daily schedule.

Some patients follow SMART therapy. Under this plan, extra puffs may be used when symptoms appear. This must only happen if a doctor gives clear instructions. Symbicort is not FDA-approved as a rescue inhaler for general use.

Exceeding prescribed doses without guidance can increase side effect risks.

How should albuterol be taken safely?

The usual albuterol dose is two puffs every four to six hours as needed. The maximum is often 12 puffs per day, depending on medical advice.

Albuterol works within minutes. Its effects last about four to six hours. Its half-life is around 6.5 hours.

Because it works fast, it is ideal for emergencies. Still, using it too often suggests asthma or COPD is not well controlled. That situation requires medical review.

How effective are Symbicort and Albuterol?

Do these inhalers actually improve breathing—or just manage symptoms?

How well does Symbicort control asthma over time?

Studies show strong results for Symbicort. In patients whose asthma remained uncontrolled on steroid inhalers alone, Symbicort improved morning lung function by about 37 liters per minute over 12 weeks.

Patients using budesonide and formoterol in separate inhalers improved by about 36 liters per minute. Those using only budesonide improved by about 5 liters per minute.

This shows that combination therapy provides much stronger breathing improvement.

Symbicort also delayed the time before asthma symptoms worsened. This indicates better long-term protection against flare-ups.

Another study found that Symbicort works fast. On the first day, nearly 80 percent of breathing improvement happened within 15 minutes. By the end of 12 weeks, about 90 percent of improvement still occurred within that same short window.

This means Symbicort offers both quick relief and long-lasting control.

How effective is albuterol during asthma attacks?

The MANDALA study compared albuterol alone with albuterol combined with budesonide. Among adults with exercise-related asthma worsening, the combination reduced severe asthma attacks by 43 percent.

Patients using the combination also needed half as much oral steroid medication during the year. Oral steroids carry serious risks, so reducing their use matters.

Another study compared albuterol delivered through a dry powder inhaler and a standard metered-dose inhaler. Both methods worked equally well. Both improved breathing safely compared to placebo.

This shows that albuterol works reliably across delivery methods.

What side effects can occur?

Can these inhalers cause more than just breathing relief?

What side effects are linked to Symbicort?

Symbicort can cause many side effects. These include:

  • Back pain
  • Flu-like symptom
  • Headache
  • Nasal congestion
  • Stomach discomfort
  • Sore throat
  • Upper respiratory infections
  • Sinusitis
  • Vomiting
  • Oral yeast infections
  • Jitteriness
  • Mild heart palpitations
  • Sinus pain
  • Stuffy nose
  • Nausea
  • Low blood potassium
  • Pneumonia
  • Blood vessel swelling
  • Osteoporosis
  • High blood sugar
  • Adrenal insufficiency
  • Glaucoma and other eye problems
  • Oral fungal infections affecting mouth or throat

Rinsing the mouth after use helps reduce the risk of oral infections.

What side effects can albuterol cause?

Albuterol side effects often relate to its fast action. These include:

  • Fast or irregular heartbeat
  • Shakiness in hands, arms, legs, or feet
  • Trembling
  • Headache
  • Dizziness
  • Sore throat
  • Runny nose
  • Muscle aches
  • Sleep problems
  • Taste changes
  • Dry mouth
  • Anxiety
  • Shortness of breath
  • Muscle cramps
  • Bad taste
  • Rapid heart rate
  • Severe allergic reactions, including swelling of the face, lips, tongue, or throat

So, which inhaler should you use?

  • Symbicort is used every day to control asthma or COPD and reduce flare-ups before they start.
  • Albuterol is used as needed for fast relief during sudden breathing problems.
  • Symbicort treats inflammation and muscle tightening, while albuterol only relaxes airway muscles.
  • Needing albuterol often suggests poor control, which means daily treatment may need adjustment.
  • Both medicines have side effects, and understanding them helps you use each inhaler more safely.
Share your story
Once your story receives approval from our editors, it will exist on Buoy as a helpful resource for others who may experience something similar.
The stories shared below are not written by Buoy employees. Buoy does not endorse any of the information in these stories. Whenever you have questions or concerns about a medical condition, you should always contact your doctor or a healthcare provider.
Jeff brings to Buoy over 20 years of clinical experience as a physician assistant in urgent care and internal medicine. He also has extensive experience in healthcare administration, most recently as developer and director of an urgent care center. While completing his doctorate in Health Sciences at A.T. Still University, Jeff studied population health, healthcare systems, and evidence-based medi...
Read full bio

Was this article helpful?

Tooltip Icon.

References

  • Johnson, D. B., Merrell, B. J., & Bounds, C. G. (2024). Albuterol. In StatPearls [Internet]. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482272/
  • AstraZeneca. (2024). Symbicort® (budesonide/formoterol fumarate dihydrate) inhalation aerosol: Indications and important safety information. AstraZeneca. Retrieved from https://www.symbicorttouchpoints.com/symbicort-indications.html
  • American Society of Health-System Pharmacists. (2025). Albuterol. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a607004.html
  • Jenkins, C., Kolarikova, R., Kuna, P., Caillaud, D., Sanchis, J., Popp, W., & Pettersson, E. (2006). Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology, 11(3), 276–286. https://doi.org/10.1111/j.1440-1843.2006.00856.x
  • Chipps, B. E., Albers, F. C., Reilly, L., Johnsson, E., Cappelletti, C., & Papi, A. (2021). Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: Rationale and design of the randomised, double-blind, active-controlled MANDALA study. BMJ Open Respiratory Research, 8(1), e001077. https://doi.org/10.1136/bmjresp-2021-001077
  • Nelson, H., Kemp, J. P., Bieler, S., Vaughan, L. M., & Hill, M. R. (1999). Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma. Chest, 115(2), 329–335. https://doi.org/10.1378/chest.115.2.329